_________________
Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934
Date of report (date of earliest event reported): June 26, 2003
| ALARIS MEDICAL, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Delaware | 1-10207 | 13-3492624 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation or organization) | Identification Number) | |
| |
||
| 10221 Wateridge Circle San Diego, CA 92121-1579 |
||
| (Address, including zip code, of registrant’s principal executive offices) | ||
| |
||
| (858) 458-7000 | ||
| Registrant’s telephone number, including area code | ||
Page 1 of 5
| On June 26, 2003, ALARIS Medical, Inc. announced today the pricing of its public offering of 9,100,000 shares of its common stock at $12.50 per share and the pricing of its public offering of $175 million aggregate principal amount of 7¼% senior subordinated notes due July 1, 2011. Concurrently with the closing of these stock and bond offerings, the Company will also establish a $245 million bank term loan and $30 million revolving credit facility. The press release is attached as Exhibit 99.1. |
| Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
| ALARIS MEDICAL, INC. |
| Date: June 26, 2003 |
/s/DAVID L. SCHLOTTERBECK ———————————————— David L. Schlotterbeck President and Chief Executive Officer |
Exhibit
99.1 Press release of ALARIS Medical, Inc., dated June 26, 2003.